KLRA compared with KMTS: revenue, margins and what each company keeps, and the suppliers and customers both name

KLRAKailera Therapeutics, Inc.

Mkt capRevenueRevenue

KMTSKestra Medical Technologies, Ltd.

Mkt capRevenueRevenue

Compare

KLRAKailera Therapeutics, Inc.

KMTSKestra Medical Technologies, Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

KLRA1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−3.34%—

KMTS

Reportimpliedrealized× implied

Sep 15 '26—▲+4.66%—

Q1 FY26—▲+1.80%—

Q3 FY26

= impliedKLRA realized, solidKMTS realized, hatchedOne scale, both sides: full bar = 8%× = |realized| ÷ impliedSource: market data

—

▼−7.38%

—

Dec 12 '25—▲+5.06%—

KLRAKailera Therapeutics, Inc.

12.13▼−5.24%· post 12.35· delayed

Mkt cap$1.7BRevenue—Revenue—

KMTSKestra Medical Technologies, Ltd.

28.15▼−7.72%· post 28.15· delayed

After hoursNov 5 '26delayed

Mkt cap$1.7BRevenue$25MQ3 FY26Revenue$60MFY25

Compare

After hoursNov 5 '26delayed

KLRAKailera Therapeutics, Inc.

KMTSKestra Medical Technologies, Ltd.

12.13▼−5.24%post 12.35delayed

Price

28.15▼−7.72%post 28.15delayed

$1.7B

Mkt cap

$1.7B

—

Revenue

$25MQ3 FY26

—

Revenue

$60MFY25

KLRA12.13▼−5.24%vsKMTS28.15▼−7.72%After hoursNov 5 '26delayed